These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21976463)

  • 21. Barriers to use of free antiretroviral therapy in injection drug users.
    Strathdee SA; Palepu A; Cornelisse PG; Yip B; O'Shaughnessy MV; Montaner JS; Schechter MT; Hogg RS
    JAMA; 1998 Aug; 280(6):547-9. PubMed ID: 9707146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients.
    Calcagno A; Piconi S; Focà E; Nozza S; Carli F; Montrucchio C; Cattelan AM; Orofino G; Celesia BM; Morena V; De Socio GV; Guaraldi G;
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):338-342. PubMed ID: 28708810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?
    Goulet JL; Fultz SL; Rimland D; Butt A; Gibert C; Rodriguez-Barradas M; Bryant K; Justice AC
    Clin Infect Dis; 2007 Dec; 45(12):1593-601. PubMed ID: 18190322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
    Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study.
    Cooper CL; Galanakis C; Donelle J; Kwong J; Boyd R; Boucher L; Kendall CE
    BMC Infect Dis; 2019 Aug; 19(1):712. PubMed ID: 31438873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation.
    Armah KA; McGinnis K; Baker J; Gibert C; Butt AA; Bryant KJ; Goetz M; Tracy R; Oursler KK; Rimland D; Crothers K; Rodriguez-Barradas M; Crystal S; Gordon A; Kraemer K; Brown S; Gerschenson M; Leaf DA; Deeks SG; Rinaldo C; Kuller LH; Justice A; Freiberg M
    Clin Infect Dis; 2012 Jul; 55(1):126-36. PubMed ID: 22534147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men.
    Palenicek J; Nelson KE; Vlahov D; Galai N; Cohn S; Saah AJ
    Arch Intern Med; 1993 Aug; 153(15):1806-12. PubMed ID: 8101438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users.
    Thomas DL; Shih JW; Alter HJ; Vlahov D; Cohn S; Hoover DR; Cheung L; Nelson KE
    J Infect Dis; 1996 Oct; 174(4):690-5. PubMed ID: 8843204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for vitamin D deficiency among HIV-infected and uninfected injection drug users.
    Lambert AA; Drummond MB; Mehta SH; Brown TT; Lucas GM; Kirk GD; Estrella MM
    PLoS One; 2014; 9(4):e95802. PubMed ID: 24756000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Echocardiographic Pulmonary Pressure in HIV-infected and -uninfected Individuals in the Veterans Aging Cohort Study.
    Brittain EL; Duncan MS; Chang J; Patterson OV; DuVall SL; Brandt CA; So-Armah KA; Goetz M; Akgun K; Crothers K; Zola C; Kim J; Gibert C; Pisani M; Morris A; Hsue P; Tindle HA; Justice A; Freiberg M
    Am J Respir Crit Care Med; 2018 Apr; 197(7):923-932. PubMed ID: 29131651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington, DC.
    Levy ME; Greenberg AE; Hart R; Powers Happ L; Hadigan C; Castel A;
    HIV Med; 2017 Nov; 18(10):724-735. PubMed ID: 28503912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapy.
    Zhang S; van Sighem A; Kesselring A; Gras L; Smit C; Prins JM; Kauffmann R; Richter C; de Wolf F; Reiss P
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):265-72. PubMed ID: 22531756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations.
    Uccellini L; Tseng FC; Monaco A; Shebl FM; Pfeiffer R; Dotrang M; Buckett D; Busch MP; Wang E; Edlin BR; Marincola FM; O'Brien TR
    Hepatology; 2012 Jul; 56(1):86-94. PubMed ID: 22331649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-reported antiretroviral therapy in injection drug users.
    Celentano DD; Vlahov D; Cohn S; Shadle VM; Obasanjo O; Moore RD
    JAMA; 1998 Aug; 280(6):544-6. PubMed ID: 9707145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for proteinuria in HIV-infected and -uninfected Hispanic drug users.
    Rhee MS; Schmid CH; Stevens LA; Forrester JE
    Am J Kidney Dis; 2008 Oct; 52(4):683-90. PubMed ID: 18572293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for HIV seropositivity in a sample of drug users in drug treatment in Ho Chi Minh City, Vietnam.
    Tran SD; Williams AB; Truong HT; Do NH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):283-7. PubMed ID: 9495230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.
    Harboe ZB; Larsen MV; Ladelund S; Kronborg G; Konradsen HB; Gerstoft J; Larsen CS; Pedersen C; Pedersen G; Obel N; Benfield T
    Clin Infect Dis; 2014 Oct; 59(8):1168-76. PubMed ID: 25038114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4/CD8 Ratio and CD4 Nadir Predict Mortality Following Noncommunicable Disease Diagnosis in Adults Living with HIV.
    Castilho JL; Turner M; Shepherd BE; Koethe JR; Furukawa SS; Bofill CE; Raffanti S; Sterling TR
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):960-967. PubMed ID: 31407605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
    Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
    HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.